Fig. 1From: Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort studyAssociation of PCSK9 and coagulation-related indicators in all patients (N = 2293). p < 0.05, PCSK9, proprotein convertase subtilisin/Kexin type 9Back to article page